RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1354
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_0407600; Gene model (P.falciparum): PF3D7_0309500; Gene product: asparagine synthetase [glutamine-hydrolyzing], putative
Phenotype Asexual bloodstage; Fertilization and ookinete; Oocyst; Sporozoite; Liver stage;
Last modified: 5 April 2016, 09:55
  *RMgm-1354
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 26531182
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherNagaraj VA; Padmanaban G
Name Group/DepartmentDepartment of Biochemistry
Name InstituteIndian Institute of Science
CityBangalore
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-1354
Principal namePbASKO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stage(Slightly) reduced growth rate of blood stages in mice
Gametocyte/GameteNot different from wild type
Fertilization and ookineteReduced ookinete production (33%)
OocystReduced ookinete production (33%); Reduced oocyst production (61%)
SporozoiteReduced oocyst production (61%); Reduced sporozoite production (69%)
Liver stageProlonged prepatent period after injecting mice intravenously with isolated sporozoites (8 days compared to 6 days of wild type sporozoites)
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of asparagine synthetase

Protein (function)
Plasmodium lacks the canonical pathways for amino acid biosynthesis and, therefore, relies mainly on host haemoglobin degradation and extracellular sources to meet its amino acid requirements. Although auxotrophic for most of its amino acids, the parasite genome encodes a few enzymes synthesizing glycine, proline, glutamate, glutamine, aspartate and asparagine, the functional significance of which remains unknown. Of these amino acids, asparagine plays a pivotal role in the parasite life cycle by serving as one of the most abundant amino acids in Plasmodium proteins. The malaria parasite has retained asparagine synthetase (AS) that catalyses the formation of asparagine from aspartate.

Asparagine biosynthesis is catalysed by two evolutionarily independent families of enzymes—AS-A and AS-B, of which AS-A catalyses the amidation of aspartate using ammonia as nitrogen source, whereas AS-B can utilize both glutamine and ammonia though glutamine is preferred under physiological conditions. Sequence analysis of the annotated Plasmodium AS revealed that the parasite enzyme belongs to AS-B, comprising an N-terminal glutamine-hydrolyzing domain representing class-II glutamine amidotransferases/N-terminal aminohydrolases superfamily and a C-terminal domain representing ATP pyrophosphatases/ adenine nucleotide alpha hydrolases superfamily. The ammonia released during glutamine hydrolysis traverses an intramolecular tunnel and reaches the active site of C-terminal domain where it reacts with b-aspartyl-AMP intermediate to form asparagine.

(In the paper evidence is presented that the parasite enzyme possesses AS-B activity)

Phenotype
(Slightly) reduced growth of blood stages in mice. Reduced ookinete, oocyst and sporozoite production. Prolonged prepatent period after injecting mice intravenously with isolated sporozoites (8 days compared to 6 days of wild type sporozoites).

Additional information
By treating mice with L-aparaginase (in order to deplete asparagine) and analysis of development of the mutant parasites evidence is presented that the lack of exogenous asparagine in combination with the absence of asparagine synthetase completely blocks ookinete and liver stage development (and blocks exflagellation of male gametocytes). Results indicate that extracellular asparagine is essential for in vivo liver-stage development.


Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0407600
Gene Model P. falciparum ortholog PF3D7_0309500
Gene productasparagine synthetase [glutamine-hydrolyzing], putative
Gene product: Alternative name
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 15'-GCCAGGGCCCAATAATTATGAAGAGATAAAAAATAATTGCAC-3'
Additional information primer 15'-UTR (forward)
Sequence Primer 25'-GCCCAGATCTTATTTTATATGCGAATACGTATTTTTTTGC-3'
Additional information primer 25-'UTR (reverse)
Sequence Primer 35'-GCCAGGTACCCACGATTGACATTAACACCATAATTATTCACG-3'
Additional information primer 33'-UTR (forward)
Sequence Primer 45'-GCCCGCGGCCGCGTGTATACAACATATATATATCCTCATTTTGC-3'
Additional information primer 43-'UTR (reverse)
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6